Abstract
Vaginal mesh has been introduced over the last two decades or more for the therapy of pelvic organ prolapse and for synthetic suburethral sling placement. While much of the data shows improved objective and some subjective success rates over other non-mesh-related approaches, the introduction of vaginal mesh does pose unique complications related to its placement. The implanting surgeon should be well aware of these complications as the management can be challenging and may require advanced surgical skills at times to avoid further adding to the initial presenting problem.
Commentary by Amanda S. J. Chung, The University of Sydney, Sydney, NSW, AustraliaRoyal North Shore Hospital, St Leonards, NSW, AustraliaConcord Repatriation General Hospital, Concord, NSW, AustraliaMacquarie University Hospital, Department of Urology, Sydney, NSW, Australia
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- IUGA:
-
International Urogynecological Asso-ciation
- ICS:
-
International Continence Society
- MUS:
-
Midurethral sling
- POP:
-
Pelvic organ prolapse
References
Nitti VW. Complications of midurethral slings and their management. Can Urol Assoc J. 2016;6(5-S2):120.
Haylen B, Freeman R, Swift S, Dwyer P, Lee J, Rizk D, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic flo. Neurourol Urodyn. 2011;30(Jan 2011):2–12.
Cohen SA, Goldman HB. Mesh perforation into a viscus in the setting of pelvic floor surgery—presentation and management. Curr Urol Rep. 2016;17(9):1–7.
Winters C, Fitzgerald M, Barber M. The use of synthetic mesh in female pelvic reconstructive surgery. BJU Int. 2006;98(s1):70–6.
Staack A, Vitale J, Ragavendra N, Rodríguez LV. Translabial ultrasonography for evaluation of synthetic mesh in the vagina. Urology. 2014;83(1):68–74.
Lee CH, Ku JY, Lee K, Lee JZ, Shin DG. Clinical application of a transurethral holmium laser excision of exposed polypropylene mesh at lower urinary tract: single surgeon experience with long-term follow-up. Female Pelvic Med Reconstr Surg. 2018;24(1):26–31.
Shah K, Nikolavsky D, Gilsdorf D, Flynn BJ. Surgical management of lower urinary mesh perforation after mid-urethral polypropylene mesh sling: mesh excision, urinary tract reconstruction and concomitant pubovaginal sling with autologous rectus fascia. Int Urogynecol J Pelvic Floor Dysfunct. 2013;24(12):2111–7.
Macedo FIB, O’Connor J, Mittal VK, Hurley P. Robotic removal of eroded vaginal mesh into the bladder. Int J Urol. 2013;20(11):1144–6.
Abbott S, Unger CA, Evans JM, Jallad K, Mishra K, Karram MM, et al. Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study. Am J Obstet Gynecol [Internet]. 2014;210(2):163.e1–8. Available from: https://doi.org/10.1016/j.ajog.2013.10.012.
Ford AA, Rogerson L, Cody JD, Aluko P, Ogah JA. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev [Internet]. 2017 Jul 31 [cited 2019 Nov 24];(7). Available from: http://doi.wiley.com/10.1002/14651858.CD006375.pub4.
Giusto LL, Zahner PM, Goldman HB. Management of the exposed or perforated midurethral sling. Urol Clin North Am [Internet]. 2019;46(1):31–40. Available from: https://doi.org/10.1016/j.ucl.2018.08.003.
Linder BJ, El-Nashar SA, Carranza Leon DA, Trabuco EC. Predictors of vaginal mesh exposure after midurethral sling placement: a case–control study. Int Urogynecol J. 2016;27(9):1321–6.
Cohen SA, Goldman HB. Mesh perforation into a viscus in the setting of pelvic floor surgery—presentation and management. Curr Urol Rep [Internet]. 2016;17(9):1–7. Available from: https://doi.org/10.1007/s11934-016-0621-3.
Krause M, Wheeler TL, Snyder TE, Richter HE. Local effects of vaginally administered estrogen therapy: a review. J Pelvic Med Surg. 2009;15(3):105–14.
Rahn DD, Ward RM, Sanses TV, Carberry C, Mamik MM, Meriwether KV, et al. Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines. Int Urogynecol J Pelvic Floor Dysfunct. 2014;26(1):3–13.
Gaines N, Gupta P, Sirls LT. Synthetic midurethral slings: exposure and perforation. In: Goldman HB, editor. Complications of female incontinence and pelvic reconstructive surgery. Cham: Humana Press; 2017. p. 177–91.
Deffieux X, Thubert T, De Tayrac R, Fernandez H, Letouzey V. Long-term follow-up of persistent vaginal polypropylene mesh exposure for transvaginally placed mesh procedures. Int Urogynecol J. 2012;23(10):1387–90.
Abbott S, Unger CA, Evans JM, Jallad K, Mishra K, Karram MM, et al. Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study. Am J Obstet Gynecol. 2014;210(2):163.e1–8.
Giri SK, Sil D, Narasimhulu G, Flood HD, Skehan M, Drumm J. Management of vaginal extrusion after tension-free vaginal tape procedure for urodynamic stress incontinence. Urology. 2007;69(6):1077–80.
Bartley J, Han E, Gupta P, Gaines N, Killinger KA, Broura J, et al. Transvaginal trigger point injections improve pain scores in women with pelvic floor hypertonicity and pelvic pain conditions. Female Pelvic Med Reconstr Surg. 2019;25(5):392–6.
Murphy AM, Goldman HB. Thigh exploration for excision of a transobturator sling. Int Urogynecol J. 2017;28(5):793–4.
King AB, Tenggardjaja C, Goldman HB. Prospective evaluation of the effect of thigh dissection for removal of transobturator mid urethral slings on refractory thigh pain. J Urol. 2016;196(4):1207–12.
Kowalik CG, Cohn JA, Kakos A, Lang P, Reynolds WS, Kaufman MR, et al. Road to recovery after transvaginal surgery for urethral mesh perforation: evaluation of outcomes and subsequent procedures. Int Urogynecol J. 2018;29(6):887–92.
Rac G, Greiman A, Rabley A, Tipton TJ, Chiles LR, Freilich DA, et al. Analysis of complications of pelvic mesh excision surgery using the Clavien-Dindo classification system. J Urol. 2017;198(3):638–43.
Duckett J, Bodner-Adler B, Rachaneni S, Latthe P. Management of complications arising from the use of mesh for stress urinary incontinence-International Urogynecology Association Research and Development Committee opinion. Int Urogynecol J. 2019;30(9):1413–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Commentary
Commentary
In this chapter, the authors have provided an excellent and thoughtful description of vaginal mesh complications, evaluation, clinical principles, and management options in the structure of four representative clinical vignettes:
-
Urinary tract perforation of mesh, with note made of the difference between erosion and perforation
-
Vaginal extrusion of mesh
-
Pain without erosion or extrusion
-
Fistula involving mesh
The authors are to be particularly commended on their considered approach to what can be highly emotionally charged and potentially litigious mesh complication scenarios.
The authors rightly acknowledge the presence of unique complications that can surround vaginal mesh implantation for the therapy of POP and SUI, and therefore the importance of the premesh implantation workup and counselling including appropriate consent process. Additionally, the authors highlight the need for appropriate follow-up and the importance of the implanting surgeon to be well versed on such mesh complications and their management following mesh implantation [23].
In the evaluation of all mesh complication clinical scenarios, a thorough history and careful examination is important, including cystoscopic and vaginal examination, to confirm whether the mesh is indeed implicated in the current clinical condition or whether it is simply an “innocent bystander.” This is particularly important in the climate of much hype and fear of mesh in some continents in recent years. Once thorough evaluation has been completed, the principles of management include the usual course of action, which include starting with more conservative management measures before more invasive mesh removal or revision measures are undertaken. A proportion of mesh complications can respond well to conservative treatment measures. An important tenet of care is to avoid creating further harm and thereby avoid compounding the initial clinical problems as much as is possible [24].
Indeed, no two mesh complications are exactly the same, and appreciation of subtleties and attention to detail are an asset to surgeons managing these difficult clinical problems. Furthermore, multidisciplinary co-operation, particularly in complex multiorgan cases, is valuable and such collegial relationships are highly desirable and to be fostered for the best care of our patients [25].
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rueb, J.J., Derisavifard, S., Vasavada, S. (2021). Mesh Complications in the Female Lower Urinary Tract. In: Kobashi, K.C., Wexner, S.D. (eds) Female Pelvic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-54839-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-54839-1_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54838-4
Online ISBN: 978-3-030-54839-1
eBook Packages: MedicineMedicine (R0)